These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

959 related items for PubMed ID: 11085348

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Appropriateness of immunosuppressive drugs in inflammatory bowel diseases assessed by RAND method: Italian Group for IBD (IG-IBD) position statement.
    Caprilli R, Angelucci E, Cocco A, Viscido A, Annese V, Ardizzone S, Biancone L, Castiglione F, Cottone M, Meucci G, Paoluzi P, Papi C, Sturniolo GC, Vecchi M.
    Dig Liver Dis; 2005 Jun; 37(6):407-17. PubMed ID: 15893279
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Current medical therapy for inflammatory bowel disease.
    Bonner GF.
    South Med J; 1996 Jun; 89(6):556-66. PubMed ID: 8638193
    [Abstract] [Full Text] [Related]

  • 9. Treating inflammatory bowel disease during pregnancy: risks and safety of drug therapy.
    Connell W, Miller A.
    Drug Saf; 1999 Oct; 21(4):311-23. PubMed ID: 10514022
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Maintenance of remission in Crohn's disease: current and emerging therapeutic options.
    Brookes MJ, Green JR.
    Drugs; 2004 Oct; 64(10):1069-89. PubMed ID: 15139787
    [Abstract] [Full Text] [Related]

  • 12. Pharmacologic therapy for inflammatory bowel disease.
    Hirschfeld S, Clearfield HR.
    Am Fam Physician; 1995 Jun; 51(8):1971-5. PubMed ID: 7762487
    [Abstract] [Full Text] [Related]

  • 13. How important is onset of action in ulcerative colitis therapy?
    Masson S, Nylander D, Mansfield JC.
    Drugs; 2005 Jun; 65(15):2069-83. PubMed ID: 16225364
    [Abstract] [Full Text] [Related]

  • 14. [Treatment of chronic inflammatory bowel diseases].
    Lémann M.
    Bull Acad Natl Med; 2007 Jun; 191(6):1125-41; discussion 1141. PubMed ID: 18402168
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [Conservative therapy of inflammatory bowel diseases].
    Nagy F.
    Orv Hetil; 2002 Dec 15; 143(50):2763-8. PubMed ID: 12583315
    [Abstract] [Full Text] [Related]

  • 17. Newer pharmacologic agents for the therapy of inflammatory bowel disease.
    Ruderman WB.
    Med Clin North Am; 1990 Jan 15; 74(1):133-53. PubMed ID: 2404172
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Generalized Pyoderma Gangrenosum Associated with Ulcerative Colitis: Successful Treatment with Infliximab and Azathioprine.
    Chatzinasiou F, Polymeros D, Panagiotou M, Theodoropoulos K, Rigopoulos D.
    Acta Dermatovenerol Croat; 2016 Apr 15; 24(1):83-5. PubMed ID: 27149138
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 48.